These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 1934530

  • 1. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z, Klinger B, Jensen LT, Erster B.
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B, Jensen LT, Silbergeld A, Laron Z.
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [Abstract] [Full Text] [Related]

  • 3. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB.
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
    [Abstract] [Full Text] [Related]

  • 4. IGF-I treatment of adult patients with Laron syndrome: preliminary results.
    Laron Z, Klinger B.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):631-8. PubMed ID: 7530175
    [Abstract] [Full Text] [Related]

  • 5. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P.
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [Abstract] [Full Text] [Related]

  • 6. Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
    Silbergeld A, Klinger B, Schwartz H, Laron Z.
    Horm Res; 1992 Sep; 37(4-5):160-4. PubMed ID: 1490658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
    Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A.
    Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.